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Drug resistance to tuberculosis (TB) has become more widespread over the
past decade. As such, understanding the emergence and fitness of antibiotic-
resistant subpopulations is crucial for the development of new interventions.
Here we use a simple mathematical model to explain the differences in the
response to isoniazid (INH) of Mycobacterium tuberculosis cells cultured
under two growth rates in a chemostat. We obtain posterior distributions of
model parameters consistent with data using a Markov chain Monte Carlo
(MCMC)method.We explore the dynamics of diverse INH-resistant subpopu-
lations consistent with these data in a multi-population model. We find that
the simple model captures the qualitative behaviour of the cultures under
both dilution rates and also present testable predictions about how diversity
is maintained in such cultures.1. Introduction
The battle to eradicate tuberculosis (TB), a disease caused by the pathogen
Mycobacterium tuberculosis, has been on for more than half a century. In 2014,
theWorldHealthOrganization estimated 9.6million newTB cases and 1.5million
TB deaths [1]. The management of human TB relies heavily on vaccination, case
finding and antibiotic treatment. Current treatments for TB are complex and
lengthy leading to incomplete treatment, non-compliance and the development
of multi-drug resistance (MDR). Unfortunately, on a global scale, drug-resistant
(DR) forms of TB have become more widespread over the past decade, with an
estimated 3.3% of new cases and 20% of previously treated cases with MDR-TB
in 2015 [1]. In particular, isoniazid (INH) and rifampicin form the core of standard
treatment regimens, and resistance to them is a keystone of MDR tuberculosis.
Understanding the emergence and fitness of antibiotic-resistant subpopu-
lations is crucial for the development of new interventions. Because it is a
highly clonal bacterium, M. tuberculosis acquires antibiotic resistance through
mutation as opposed to DNA acquisition. For INH, clinically relevant resistance
mutations have been identified, primarily in katG and inhA. katG encodes for the
catalase-peroxidase responsible for activating the pro-drug INH and approxi-
mately 50–90% of all clinical INH-resistant isolates have a mutation at katG
codon Ser315 [2]. In addition to katG and inhA, other mutated genes have been
found in INHR (resistant) isolates [3–8]. Resistance can arise due to selection of
randomly generated pre-existing resistance-conferring mutations, or by less
direct mechanisms such as development of tolerance to hostile environments
which can then confer compensatory advantages in the event that a population
is exposed to antibiotics [9–11]. Drug tolerance may also be due to the expression
of a phenotype that limits drug activity. For example, during INH exposure, epi-
genetic events leading to KatG pulsing result in a pattern of dynamic persistence
[12]. Exposure to antibiotics can also lead to hypermutability and resistance. It has
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that a slowing in the bactericidal activity of INH following an
early rapid reduction in the bacterial population resulted
from the selection of phenotypically tolerant slow-growing
‘persisters’ and not the emergence of resistant subpopulations
[13]; these persisters may play an additional role in the evol-
ution of resistance [14]. In contrast with these findings,
hollow-fibre studies suggested that the cessation of the bacteri-
cidal activity of INH was as a result of a rapid emergence of
antibiotic resistance and not the depletion of the exponential
phase growth [15]. However, this requires further investigation
as clinical data on the levels of antibiotic resistance in patients
during early bactericidal activity studies revealed that anti-
biotic resistance was never encountered in INH monotherapy
trials [16]. It remains unclear how the slow growth ofM. tuber-
culosis contributes to INH tolerance. It is possible that slow-
growing, metabolically inactive bacilli predominate in
sputum after initial INH-mediated sterilization of the exponen-
tially growing bacilli. One approach to answering these
questions is to study the response of TB to different growth con-
ditions in culture.
Bacilli in pulmonary cavities are thought to be growing in
an aerobic environment and, therefore, behave in a way that
can be imitated by in vitro systems like the chemostat [17].
The chemostat has been used to study and capture the
response of MBT cells to specific challenges such as carbon
limitation [18,19], oxygen limitation [20] and nutrient limit-
ation [21]. Chemostat models of M. tuberculosis growing
under fast and slow dilution are thought to be good models
for the different phases of tuberculosis, an acute phase and
an asymptomatic/persistent phase, respectively [19,22,23],
although it is clear that an in vitro system cannot truly capture
the bacteria’s environment within a host. However, TB is chal-
lenging to work with, there are limited animal models, and the
ability to control the conditions and intervene in a controlled
way presents good opportunities to directly observe the evol-
ution of TB under known selective pressures. Briefly, a
chemostat consists of three compartments: the nutrient reser-
voir, the vessel containing the bacterial culture (growth
chamber) and a tank to collect waste. Via an inflow from the
nutrient reservoir, fresh nutrition is added to the culture
vessel which usually contains a single or mixed bacterial
population. Via an outflow to the tank, bacteria are harvested.
Bacteria (B) grow in a chemostat feeding on a limiting resource
R. The net growth rate of the bacteria is controlled by a con-
stant dilution rate D. This is the rate of inflow and outflow
from the chemostat. It represents the fraction of the volume
in the chemostat being replaced per unit time.
Recently, Jeeves et al. [24] interrogated populations of
M. tuberculosis cells cultured under fast dilution rates
(0.03 h21) or slow dilution rates (0.01 h21) in continuous cul-
tures (to achieve pre-drug exposure mean generation times of
23.1 h and 69.3 h, respectively) in order to understand how
the slow growth of M. tuberculosis contributes to INH toler-
ance. Genotypic analyses were performed to determine the
effect of different growth rates on the mutant frequency
and the development of katG mutations. Phenotypic adap-
tation to INH under different growth rates was also
explored using RNA tiling arrays. They found that bacterial
numbers recover at both dilution rates after an initial rapid
decline in population size. Under a fast dilution rate
(0.03 h21), numbers stabilized well below the original cell
density prior to INH exposure, but under the slow dilutionrate (0.01 h21), the cultures were able to completely regain
their original population size. The mechanisms permitting
this complete recovery under the slow dilution rate but not
under the fast dilution rate are not known. In addition,
sequencing of the katG Ser315 locus of INH-resistant colonies
isolated from the chemostat cultures (by plating on to 2
MIC INH) revealed distinct differences in the mutation pro-
files: under the slow dilution rate there were high
frequencies of the katG codon Ser315 mutation (up to 37%
of mutant colonies), whereas under fast dilution less than
14% of mutant colonies had a mutation at this locus.
Rather, the colonies isolated from fast-dilution rates had a
more diverse range of mutations elsewhere in the katG gene.
Here we use a simple mathematical model to explain the
differences in the responses to INH of bacilli cultured at two
different growth rates. We use a Markov chain Monte Carlo
(MCMC) method to obtain posterior distributions of model
parameters consistent with data. The results explain how the
dilution rate affects the population dynamics. We use these
posterior parameter distributions to define diverse collections
of resistant subpopulations consistent with the observed
growth curves, and place these resistant populations in a
multi-population model to study diversity through time. We
can account for the observed differences in population
dynamics and diversity in a very simple way that does not
require populations of slow-growing persisters, hypermutabil-
ity or emergence of compensatory mutations (though these
may be present nonetheless). We present testable predictions
about how diversity is maintained in such cultures.2. Material and methods
2.1. Experimental methods
The methods used to culture M. tuberculosis at different growth
rates have been described previously (Jeeves et al. [24]). However,
for ease of interpretation of the current study, the method is briefly
described here. Mycobacterium tuberculosis (strain H37Rv) was
grown in chemostats under controlled conditions as described pre-
viously [25]. We culturedM. tuberculosis on glycerol as the limiting
nutrient. Three replicate cultures were performed at two different
dilution rates to steady state [20,22]. The cultures achieved a mean
generation time (MGT) of 23.1 h (dilution rate of 0.03 h21; fast
growth) or an MGT of 69.3 h (dilution rate 0.01 h21; slow
growth). The antibiotic was then added during steady state at a
minimum inhibitory concentration (MIC) of 0.5 mg l21 and main-
tained at this level in culture throughout each time-course. Viable
count analyses were performed throughout the culture time-
courses. In the main text, we present model analysis based on
pooled replicates and in the electronic supplementary material
we analyse replicate cultures separately.2.2. Mathematical model
We developed a mathematical model for the continuous culture
of M. tuberculosis cells exposed to MIC levels of INH. In the basic
model, we include two bacterial subpopulations: B1, sensitive to
INH and B2, resistant to INH. Resistant bacilli arise from the sen-
sitive population by mutation at rate m (we do not consider
reverse mutation). Both subpopulations grow by consumption
of the resources and are washed out at the (constant) dilution
rate. The resources are consumed by the bacteria at a rate pro-
portional to their resource-dependent growth rate and a
conversion efficiency parameter e, which is the amount of
resource required to produce a single new cell [26].
Table 1. Deﬁnitions of all states and parameters.
symbol deﬁnition
states
B1 susceptible bacterial subpopulation (CFU ml
21)
B2 resistant subpopulation (CFU ml
21)
R resource concentration (mg ml21)
variables priors  U(a, b)
a b
m mutation rate (h21) 2.56  1028 2  1026
A^ bacteriostatic action of INH 0.01 0.99
P antibiotic bactericidal rate (h21) 0 4
e1 conversion efﬁciency parameter of B1 (mg CFU
21) 5  10210 2  1028
e2 conversion efﬁciency parameter of B2 (mg CFU
21) 5  1029 2  1027
D dilution rate (h21) — —
C resource input concentration (mg l21) — —
l1 maximum growth rate of susceptible subpopulation (h
21) 0.03 0.05
l2 maximum growth rate of resistant subpopulation (h
21) 0.02 0.04
k1 half saturation constant of susceptible subpopulation (mg l
21) 0.01 0.03
k2 half saturation constant of resistant subpopulation (mg l
21) 0.02 0.06
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maximum growth rates (li), different yield constants (e i) and
different half saturation constants (ki; the concentration of
resource at which a population reaches half its maximum
growth rate), so resistance can confer a fitness cost. The
resource-dependent growth rate, fi(R) for the two populations,
is given by fiðRÞ ¼ liR=ðki þ RÞ. Models of continuous culture
are well established and typically follow this pattern [27–29].
We model the effect of INH using two parameters, A^ and P, to
represent reduction in growth (by a factor 1A^) and bactericidal
effect (at rate P), respectively. We also consider a situation where
drug efficacy depends on growth rate and where bacteria whose
growth is suppressed by the drug consume less of the resource
rather than simply producing less growth for a given resource con-
sumption (see the electronic supplementary material); results are
unchanged by these modifications.
The model equations are
dB1
dt
¼ B1ðð1A^Þf1ðRÞ  m PDÞ,
dB2
dt
¼ B2ðf2ðRÞ DÞ þ mB1
and
dR
dt
¼ DðC RÞ  e1f1ðRÞB1  e2f2ðRÞB2:
9>>>>=
>>>>;
For a full description of the parameters, see table 1.
2.3. Model parameters and Bayesian Markov Chain
Monte Carlo approach
We used a Bayesian MCMC approach to find posterior sets of
parameters related to antibiotic activity (A^, P), half saturation
constant (k), conversion efficiency parameter (e) and mutation
rate (m). We fit to all data points (replicate cultures) pooled
together; fits to individual cultures are provided in the electronic
supplementary material. Mycobacterium tuberculosis cells are gen-
erally characterized as being slow growers with a maximum
growth rate not exceeding 1/16 divisions per hour in optimum
conditions [19]. We choose values of lm within the range(1/2321/20) h21 [30]. For the fitting procedure, the smallest
mutation rate of M. tuberculosis cells during exposure to INH is
chosen to be 2.56  1028 per cell per generation [31]. We do
not include the dilution rate D and nutrient concentration C in
the MCMC procedure as these are known and fixed.
Prior to the addition of INH to the chemostat cultures, the
M. tuberculosis cells were grown to steady state at densities of
approximately 108 CFU ml21. During this period of growth,
mutation can occur, and it can be expected that small numbers
of different subpopulations will arise from these large popu-
lations undergoing continuous turnover [32]. Accordingly, it is
very unlikely that there would be absolutely no cells of minority
subpopulations in a system with 108 CFU ml21. Despite this, we
avoid directly introducing resistant subpopulations, and instead
initialize the model with sensitive cells only, at their steady-state
values prior to addition of INH. We allow the resistant subpopu-
lation to arise through mutation and persist (or not, depending
on its fitness in the system without INH) to reach its steady
state before we add INH. We also set the initial value of R to
be the pre-drug steady-state value.
We used MCMC to fit model parameters by maximizing the
likelihood derived from the assumption of Gaussian scatter
(minimizing the sum of squared differences), using the Matlab
MCMC package by Haario et al. [33]. We based our likelihood
on the weighted squared error function x2(u) in the usual
way, with
x2ðuÞ ¼
Xm
i¼1
Xn
j¼1
Bdij  Biðu, tjÞ
sdij
 !
,
where Bdij are the n data points for each observable m, B(u, ti) is
the solution of the m-dimensional dynamical system at time
point i, and sdij are the corresponding measurement errors [34].
This is equivalent to using the likelihood L(u) [35], where
x2ðuÞ ¼ 2 logðLðuÞÞ, ð2:1Þ
under the assumption of Gaussian noise. The MCMC procedure
produces a posterior collection of parameter sets corresponding
to model trajectories that fit the data.
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Figure 1. Grey lines (a) show the fits from 500 parameter sets randomly drawn from the posterior distribution of viable bacterial numbers for slow and fast dilution
rates, the red lines (b) are the B1 population (INH sensitive), the blue lines are the B2 population (INH resistant) and the cyan (c) lines are plots of the resource
concentration. (Bacterial counts are in log base 10). Right panels: long transient dynamics have been suppressed.
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The posterior collections of parameters represent alternative
parameters under which the model can match the observed
data. As is often the case with dynamical models of biological sys-
tems, parameters are not uniquely determined by observations,
due to complex nonlinear dependencies and trade-offs. We take
the posterior to represent diverse ways that we can define a
model subpopulation that is tolerant of INH and whose popu-
lation dynamics follow the observed data. Accordingly, we use
the posterior to extend the model to represent multiple, different
subpopulations. We model m distinct mutations that could cause
an M. tuberculosis bacillus to evade the action of INH. The suscep-
tible subpopulation B1 mutates to create each of these m resistant
subpopulations at different rates. Each subpopulation takes its
parameter combination (l2, e2, k2) from the estimated posterior,
so that each subpopulation exhibits different maximum growth
rates li(R), different yield constants ei and different half saturation
constants, ki, as we assume that some mutations are more expens-
ive than others. This allows us to use the posterior parameter
distributions for resistant subpopulation to explore the relation-
ship between mutation and selection (which has multiple
flavours: drug resistance/tolerance, growth before dilution and
efficient use of resources) in this system.
The differential equations are
dB1
dt
¼ B1ðð1 A^Þf1ðRÞ  m PDÞ,
dB1
dt
¼ BiðfiðRÞ DÞ þ miB1, i ¼ 2, . . . ,m
and
dR
dt
¼ DðC RÞ 
Xn
i¼1
eifiðRÞBi,
9>>>>=
>>>>;
ð2:2Þ
where
m ¼
Xn
i¼2
mi:
We assume that mutations giving rise to the different sub-
populations occur at different rates, i.e. we use different valuesof mi. If the subpopulation with the least fitness costs are assumed
to appear faster than other subpopulations, then this gives them an
advantage. Therefore, in our model simulation, we assume that
mutations that confer higher net growth occur at a lower rate
than mutations with lower net growth. Removing this assumption
does not change the population dynamics, likely because the ulti-
mate fate of each subpopulation depends more on its fitness cost
than on the rate at which it appears in the system.
2.5. Diversity measure
A range of diversity indices have been used with bacterial commu-
nities [36–38]. Here we analyse diversity using Shannon’s index H0
[39], which is defined as H0 ¼ Pni¼1 Pi lnPi, where Pi is the
proportion of the total population occupied by subpopulation i.3. Results
The model captures the qualitative behaviour of the cultures
in [24] under fast- and slow dilution rates. No fine tuning of
parameters is necessary: the model is robust in the sense that
a range of parameters fits the data as shown in figure 1. For
baseline values of parameter fits for slow and fast dilution
rates, see tables 2 and 3, respectively. Matching the observed
data does not require modelling slow-growing persisters or
an explicit lag phase. However, the mutation rates and
large population sizes result in a sizable minority population
(of order 105) of resistant bacteria at the time that INH is
added; this is a combination of inferred mutation rates and
growth and turnover of the steady-state population of order
108 or higher prior to the addition of INH. We also note
that in order to fit the steady-state bacterial numbers before
the addition of INH, we require differences in the yield coef-
ficient e i between the two dilution rates. While this appears
counterintuitive, it has been predicted previously [19,40,41],
and may also be related to the higher expression of genes
Table 2. Baseline values of parameter ﬁts (slow dilution).
parameter mean
2.5th
percentile
97.5th
percentile
m 3.01  1026 2.32  1026 6.68  1026
A^ 0.04 0.027 0.95
P 0.06 0.03 0.10
e1 5.46  1028 2.61  1029 1.07  1028
e2 8.46  1028 2.69  1028 1.77  1027
l1 0.041 0.031 0.049
l2 0.027 0.021 0.037
k1 0.019 0.01 0.03
k2 0.04 0.02 0.05
Table 3. Baseline values of parameter ﬁts (fast dilution).
parameter mean
2.5th
percentile
97.5th
percentile
m 5.33  1026 2.14  1026 6.94  1026
A^ 0.50 0.03 0.96
P 0.06 0.03 0.09
e1 7.29  1029 5.06  1029 1.26  1028
e2 4.83  1027 1.07  1027 1.08  1026
l1 0.03 0.04 0.05
l2 0.03 0.036 0.04
k1 0.02 0.01 0.03
k2 0.03 0.02 0.04
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dilution post-INH addition [24]. Pressure to use the carbon
source most efficiently may be weaker under fast dilution
than slow dilution, consistent with the model’s prediction
of excess glycerol in the medium.
Figure 1a shows the model’s growth curves alongside
observed data. The susceptible population B1 dies off rapidly
upon addition of INH, leading to a temporary excess of gly-
cerol. Figure 1b shows that the resistant subpopulation begins
to grow immediately—the apparent lag phase in the rise of
this resistant population is due to the initial decline in the
total viable count because the vast majority of bacteria are
sensitive to INH (type B1 in the model) when the antibiotic
is first added. While the population size begins to expand
again in both the fast- and slow dilution rates, under slow
dilution the bacteria have time to maximize use of the
excess nutrient with an apparent increase in growth rate,
which in turn enables the population to re-establish the orig-
inal population size. By contrast, a lower but fairly constant
population size of resistant bacteria is eventually maintained
under the fast dilution rate (as observed by Jeeves et al. [24]).
To aid interpretation of this, at the time that INH was added
to the cultures, the bacteria under fast dilution were dividing
at a rate very close to the maximum physiologically achiev-
able growth rate for M. tuberculosis, as it has been
determined previously that increasing the dilution rate to
higher than a MGT of 23.1 h MGT resulted in wash-out of
the cultures. If this is the maximum physiologically achiev-
able growth rate, then an increase in the growth rate (and,
therefore, an increase in biomass) is not possible even in the
presence of excess glycerol. This may account for why fast
dilution cultures could not recover their original population
size. We note, however, that if left to run for a longer time
period, the cultures under fast dilution may very slowly
increase, possibly up to similar levels to those attained by
the cultures under slow dilution.
Under steady-state conditions, the imposed slow and fast
dilution rates (0.01 h21 and 0.03 h21, respectively) in the che-
mostat correspond to slow and fast bacterial growth, and this
is a motivation for the use of continuous cultures as models
for chronic disease (slow dilution rates) and acute disease
(fast dilution rates) M. tuberculosis infection [22,42] (tables 2
and 3). The comparison of two distinctly different growth
rates in a controlled and defined system enabled us to
measure the direct effect of growth rate on the response of
M. tuberculosis to INH exposure. However, once the system
departs from steady state (in this case when INH was
added), growth rates and dilution rates are not necessarily
the same. At times, the growth rate under slow dilution
reached the growth rates imposed by fast dilution (figure 2).
There are wide ranges of posterior parameters that allow
the model the match the data, and most posterior parameters
are similar under fast and slow dilution (figure 3). A few
show marked differences: l2, k1, P, m and e2 are higher
under fast dilution and there are some correlations (electronic
supplementary material, figures S4, S5). The kill rate P and
mutation rate m have a difference of about an order of mag-
nitude between the two dilution rates, consistent with
Jeeves et al.’s measurement of mutation rates of 1027 and
1026 per cell per generation in slow- and fast dilution,
respectively. We recognize that the model has parameters
whose roles overlap: for example, both A^ and P reflect anti-
biotic action, and both li and ki determine how growthdepends on the resource. As such, parameters are not statisti-
cally identifiable from the data we have, and instead of
attempting to find maximum-likelihood estimates of each
parameter we have taken a Bayesian approach to find pos-
terior collections of parameters sets where the model
matches the data. We draw conclusions not about the
values of specific parameters, but about dynamics we find
using all posterior sets of parameters. We explore further
identifiability and correlation structure in the posteriors in
the electronic supplementary material.
The posterior parameters defining the resistant subpopu-
lation allow us to explore the estimated fitness cost of INH
resistance. An intuitive way to define the relative fitness in
this context is the ratio of growth rates between resistant
and sensitive subpopulations:
f ¼ f2ðRÞ
f1ðrÞ
¼ l2=ðk2 þ RÞ
l1=ðk1 þ RÞ :
This depends on the level of resource R: relative fitness is
specific to an environment. When R ki, f  l2=l1, and
when R ki, f  ðl2=k2Þ=ðl1=k1Þ. Figure 4 shows how the
recovery is affected by l2 and k2, under slow- and fast
dilution rates. Under fast dilution, the recovery depends
very sensitively on the fitness costs, whereas under slow
dilution, recovery is much more robust to small changes in
the growth parameters. The lower panels of figure 4 shows
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two dilution rates. While slow dilution allowed more rapid
recovery of the bacterial population, the relative fitness
values of the minority subpopulation that are performing
this recovery are notably lower than the corresponding fast
dilution subpopulation. This is because under slow dilution,
subpopulations can stay in the system long enough to con-
sume the resource; competition for this now-depleted
resource means that the most fit quickly dominates. Under
fast dilution, all remaining subpopulations can grow quickly
enough to outpace the rapid dilution, but they cannot con-
sume all of the resource before being washed out (they do
eventually, but not until quite a bit later than their slow
dilution counterparts).We explored a model with a diverse resistant subpopu-
lations whose parameters are drawn from the posterior
distribution that matches the data and found that the diver-
sity patterns differ markedly under the two dilution rates
(figure 5), with fast dilution allowing a wider diversity of
subpopulations for a much longer period than slow dilution.
Previously, mutants were isolated from fast and slow dilution
rates by selection on agar containing 2MIC INH, and resist-
ance was characterized by sequence analysis of katG, which
encodes the catalase-peroxidase activity and is responsible
for activation of INH. In parallel with our observations in
the model, greater diversity in the katG gene was observed
under a fast dilution than slow [24]. This may be surprising
given that fast dilution provides very strong selective
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there is an excess of the growth resource under fast dilution,
with the effect that there is reduced competition for resources
between subpopulations. The effect of dilution rate on
diverse population interactions in chemostat systems has
been noted previously [43,44], without the focus on resistance
and diversity.
In chemostat cultures of multiple competing populations,
it is known that the subpopulation with the smallest break-even resource concentration wins and competitively excludes
the others [29,45,46]. A population’s break-even concen-
tration is the resource concentration it requires to support
growth that balances death and dilution. It depends on the
dilution rate and two parameters intrinsic to the population,
li and ki, which we draw from posterior parameter values to
reflect different fitness costs. After the susceptible bacteria
have been depleted, the system, therefore, reduces to one
with several competing subpopulations that are unaffected
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is, the lower its break-even concentration. The proportion of
the total population occupied by a subpopulation varies
inversely with its fitness cost. After the susceptible subpopu-
lation dies off, the resistant subpopulation with the least
fitness cost will have the highest proportion of the total popu-
lation (figure 5). Accordingly, in our fast dilution model
system, the model cultures will eventually reach a steady
state with one dominant subpopulation (ignoring onward
generation of diversity by mutation), but our simulations
indicate that it would take very long times to reach this equi-
librium. We did not model the mechanisms of INH resistance
and their dependence on the dilution rate, but it has been
observed that susceptibility to ribosome-targeting antibiotics
can be decreased under slow growth [47] in other organisms.
Here, while growth parallels dilution rate at steady state, it is
not fixed during the experiment. Furthermore, the observed
recovery of the bacterial populations reflects not only the
strength of INH resistance but also the resource availability,
competition and dilution.54. Discussion
We modelled M. tuberculosis growth and diversity in continu-
ous culture under the action of INH. We obtained posterior
parameter distributions for which the model matches observed
data on the recovery of the population during addition of INH,
and explored the dynamics of diverse INH-resistant subpopu-
lations consistent with these data. The model robustly matches
observed growth curves and provides a platform for exploring
the emergence of resistance to INH in continuous culture.
While the posteriors contain numerous sets of model
parameters that allow the model to match observations, all
of these parameter sets give rise to the conclusions we
report. Even though fast dilution provides very strong selective
pressure in favour of rapid cell division, fast dilution resulted
in excess resource compared to slow dilution, and the diversity
of model subpopulations that could be maintained over long
periods was greater under fast dilution. This is consistent
with the observations of Jeeves et al. [24] regarding diversity
in katG mutations. We interpret this result in the context of
fitness and inter-population competition.
Mutation-selection dynamics lead to removal of non-
beneficial mutations in a population. However, in a system
like ours where there are several beneficial mutations which
vary in fitness, the balance between mutation and selection
is complex as selection acts in several distinct ways on this
variation [48]. Fitness is often framed as a one-dimensional
variable capturing an organism’s overall capability for
growth. This depends on the environment as well as on the
organism itself. In our continuous culture system, the ability
to divide before being washed out, the strength of resistance
to INH, and the ability to consume the carbon source before
competitors and to use the carbon efficiently are distinct
elements of the fitness of subpopulations. The relative impor-
tance of these aspects of fitness is different under the
two dilution rates. Fast dilution confers strong selection in
favour of rapid division, and might, on that basis, be
expected to permit less diversity than slow dilution. How-
ever, fast dilution also results in excess glycerol in the
medium, weakening competition for resources. It appears
that the effects of reduced competition are a stronger driverof diversity in this system than the effects of strong selection
for rapid growth. The fact that the conversion parameter e2
was inferred to be much larger under fast dilution than
under slow dilution supports the notion that selection for
rapid carbon usage is lower under fast dilution.
An increased capacity of cultures to give rise to mutants
(reflected in the mutation rate) increases the adaptability of
these cultures to harsh conditions [49]; this could be reflective
of the adaptation of clinical populations to the host environ-
ment. As the posterior values of the mutation rate are notably
higher under fast dilution than under slow dilution, one
might expect that cultures in fast dilution would be able to
recover more easily. However, the potential advantages con-
ferred by rapid mutation may be outweighed by the pressure
of fast dilution, the occurrence of deleterious mutations and
the fact that the fast dilution rate may reach the physiological
limit of M. tuberculosis’ growth capacity. All these factors
combine to affect the outcome of mutation-selection balance
in this system, resulting in higher long-term diversity under
fast dilution than under slow dilution.
The competitive exclusion principle observed in chemostat
cultures is based on the assumption that the cultures do not
undergo continuous mutations. However, this is not the situ-
ation when a clonal population diversifies into a number of
subpopulations [49–51]. Continuous mutation maintains
long-term diversity with many minority subpopulations, and
would do so under either dilution rate. We do not explicitly
model diversity arising from resistant subpopulation, instead
assuming that each subpopulation’s descendants carry the
subpopulation’s growth parameters. The diversity we model,
therefore, reflects the diversity of phenotypic growth par-
ameters rather than overall genetic diversity, which would
continue to accrue at a low rate consistent with the low
genome-wide mutation rate of M. tuberculosis.
The model raises questions that can be answered in
further chemostat studies: does high resource availability
delay the end course of exploitative competition? What deter-
mines the mutation rate and how does it affect the evolution
and fitness of resistance? Studies combining whole-genome
sequencing with monitoring of the resource concentration
will provide tests of the predictions we have made, as well
as insights as to the continuous generation of diversity after
the drug-sensitive cells have died out.
The emergence of fit DR TB subpopulations is a major
concern for global health. Gagneux et al. [11] report that
mutant subpopulations with the least fitness cost to rifampi-
cin are the most prevalent among rifampicin-resistant
isolates. Many tuberculosis patients are hosts to resistant sub-
populations arising during growth and turnover of drug-
sensitive infections [11,52–54]. Following early studies that
found that TB patients given a single drug developed resist-
ance due to minority subpopulations [25,55], standard TB
treatment regimens include four antibiotics taken over
many months. Resistant minority populations have a selec-
tive advantage in patients during drug therapy and may
spread onwards, gaining in fitness over time. It is reasonable
to assume that upon emergence, resistant subpopulations
compete with their drug-susceptible progenitors for
resources. If continuous culture systems are a model for in-
host infection, our results suggest that drug selection occurs
when host resources are likely to be plentiful—during slow
growth periods of the infection or when bacterial numbers
have declined after early bactericidal action—giving rise to
rsif.royalsocietypublishing.org
J.
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 on November 9, 2016http://rsif.royalsocietypublishing.org/Downloaded from diverse resistant subpopulations. Our model does not require
slow-growing persisters or hypermutability in response to
antibiotic action or other advantages beyond simple mutation
in order to match observed complete recovery of bacterial
populations. Even in the very simple, constrained and
highly selective environment of nutrient-limited continuous
culture systems, M. tuberculosis can rapidly generate fit DR
mutants that can establish long-term survival.
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